Risankizumab is an effective treatment option for patients with psoriatic arthritis (PsA), according to a recent meta-analysis. Risankizumab showed superior efficacy across multiple outcomes compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback